Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
NFlection Therapeutics
3204
NFlection Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
NFlection focuses on the development of novel therapies to address the needs of patients with neurofibromatosis type 1.
Suggest edits
Founded
2014
Raised
$20M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Formlabs
Money Mover
Akamai
General Catalyst
Companies in the same industry
Prosensa
BrainStorm Cell Therapeutics
Cidara Therapeutics
Nativis Inc.
Lantern Pharma Inc
ELSALYS BIOTECH
Kyn Therapeutics
Cedilla Therapeutics
ABAC Therapeutics (ABAC)
AbCellera Biologics
Overview
Funding
1
Add info
Latest funding
$20,000,000
Venture capital (Series A) - 2020
F-Prime Capital
venBio Partners
Team Size
1–10
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$20,000,000
Venture capital (Series A)
FinSMEs
NFlection Therapeutics Raises $20M in Series A Funding
